1. Home
  2. Site Search

Site Search

Site Search

Displaying results 121 - 130 of 601

Project dissemination

Content | 21/11/2018
IMI1 project dissemination IMI1 project partners have a contractual obligation to disseminate the foreground (Art. II.34 of the Annex II – General Conditions of the Grant Agreement). For more information please check our guidelines on dissemination for IMI1 projects. IMI2 project ...

Project communications

Content | 21/11/2018
Communication is an important activity for all IMI projects, a fact that is recognised in the legislation creating IMI and the model Grant Agreements for both IMI1 and IMI2 projects. We have created an IMI Project Communications Guide which sets out the rules that all IMI ...

Taking a tailored approach to type 2 diabetes

News | 16/11/2018 |
Success stories from projects
IMI's RHAPSODY project researchers have split type 2 diabetes into subgroups and are working on a tool to personalise treatment for the disease. Their aim is to help patients get the best possible care for their specific condition and cut public health costs.
Illustrative image

Fast, effective treatment for autoimmune rheumatic diseases

News | 12/10/2018 |
Success stories from projects
Autoimmune rheumatic diseases like rheumatoid arthritis, lupus and scleroderma are debilitating and occasionally life-threatening. IMI's PRECISESADS project aims to improve treatment by getting the right therapies to the right patients, fast.
Illustrative image

Remote monitoring boost for long-term patients

News | 11/10/2018 |
Success stories from projects
Patients with long-term medical conditions, such as depression, multiple sclerosis and epilepsy, need regular monitoring, but having to visit the clinic frequently for tests can be a problem. IMI's RADAR-CNS project is aiming to implement real-time, on-demand monitoring through ...
Wearable device

Collaboration key to advancing regulatory science

News | 01/10/2018 |
Press releases
Representatives of regulatory authorities on both sides of the Atlantic have highlighted the importance of collaboration for advancing regulatory science. The message is a key outcome of a regulatory science summit organised by the Innovative Medicines Initiative (IMI), in ...